All Infection Prevention & Control articles – Page 6
-
NewsMystery of why some toads survive deadly fungus revealed
The mystery of why some populations of amphibians recover following outbreaks of a deadly fungus has been solved in a new study. Researchers looked at peptides that the toads secreted from their skin – a key part of their immune defence.
-
NewsFirst-of-its-kind computer model of bacterial biofilms could support antibiotic resistance research
Faster and more effective ways to treat Pseudomonas aeruginosa could be on the cards thanks to a first-of-its-kind 3D computer model which shows how the bacterium grows and reshapes its protective layer and spreads to new surfaces.
-
NewsClinical trial aims to break the cycle of recurrent urinary tract infections with bacteria’s natural enemies
Researchers’ data-driven microbiological and phage therapy approaches may help move phage therapy beyond case-by-case experimental use toward a strategy that is predictable, measurable and clinically interpretable.
-
NewsPlant-based wound dressing fights infection before it takes hold
A new dressing made from plant-based materials can deliver antibiotics directly to wounds during critical early stages of infection, according to researchers. The study is the first to use this family of sustainable furan-based polymers for infection-fighting wound dressings.
-
NewsThe family tree of viruses just grew – and it paves the way for a new approach to agricultural research
Researchers have discovered that a group of viruses known to infect an agriculturally important plant pathogen has remained genetically stable for an astonishing four decades. The work also led to the classification and naming of the group of phages.
-
NewsWhen a lip ulcer isn’t what it seems: Rare case of syphilis mistaken for mouth injury
Any lip ulcer that is painless, firm, and persists beyond two to three weeks should prompt syphilis testing, even if the presentation does not fit the typical genital picture, warn scientists presenting an unusual case study.
-
NewsNew clues raise hopes for better treatment of RSV in babies
Future therapies for respiratory syncytial virus must target both the virus and its immune response to ensure babies get the best possible outcomes, finds a new study that developed a lab model of baby lungs to show why RSV makes infants so much sicker than adults.
-
NewsFirst clinical proof of concept for ibuprofen as an adjunctive treatment for tuberculosis
Scientists have published the results of a phase IIa pilot clinical trial assessing ibuprofen as a host-directed therapy in patients with pre-extensively drug-resistant tuberculosis (pre-XDR-TB) and extensively drug-resistant tuberculosis (XDR-TB).
-
NewsHelpful microbes could battle pathogens in our hospitals and schools - with the help of AI to make it work
Helpful microbes that combat harmful pathogens could be the answer to rising antimicrobial resistance, particularly within built environments such as hospitals, homes and schools, says a new review.
-
NewsNew antiseptic capable of eliminating 99.9% of Candida parapsilosis cells
A 0.5% alcohol-based chlorhexidine antiseptic, combined with the natural organic compounds eugenol and menthol, can eliminate 99.9% of Candida parapsilosis cells. This fungus is one of the leading causes of infections in hospital settings.
-
NewsTwo companion papers explain immune ‘exhaustion’ - and how we might prevent it
Chronic and viral infections can literally exhaust certain key cells in the immune system from a constant barrage of attacks. But a new pair of papers has now pointed a way to understand how this exhaustion happens at a molecular level.
-
NewsInternational study maps high risk hotspots of Noma disease in Nigeria
A collaborative international research team has now produced the most detailed mapping of noma incidence risk in Nigeria, uncovering previously unrecognised high-risk areas and providing an important new tool to support prevention and early detection efforts.
-
NewsBrazil, Malaysia, and Thailand set to start global clinical trial to test promising dengue treatment
Following a licensing agreement signed between the Serum Institute of India (SII) and DNDi, a Phase III clinical trial is expected to begin early next year, with the aim of developing a safe, effective, and globally accessible therapeutic for dengue.
-
NewsChikungunya fever: Etiology, pathogenesis, and management, with evidence-based application of traditional Chinese medicine
Traditional Chinese medicine (TCM) offers complementary strategies for acute symptoms and chronic polyarthralgia in Chikungunya infection. A review synthesizes current knowledge on etiology, pathogenesis, clinical features, and management.
-
NewsHow immune cells in our gut mesentery fight salmonella
Researchers have found that immune cells in a portion of the abdominal cavity, called the mesentery, play a critical role in suppressing — or exacerbating — salmonella infection.
-
NewsBiochar ‘switches on’ natural oxygen chemistry to suppress soil-borne pathogens and reshape healthier microbial communities
A new study reveals how specially prepared biochar can directly suppress a destructive soil-borne pathogen while helping rebuild a richer and more stable soil bacterial community.
-
NewsBronchiectasis and NTM Research Registry data featured in four World Bronchiectasis Conference abstracts
The Bronchiectasis and NTM Association announced that research leveraging data from the Bronchiectasis and NTM Research Registry was featured in four abstracts presented at the World Bronchiectasis Conference.
-
NewsNew study advances dry mRNA vaccine patch design
New research could help make future mRNA vaccines easier to store and distribute. The study identified conditions that help protect the particles that carry mRNA in dry vaccine patches, offering practical guidance for future patch design.
-
NewsFighting the world’s deadliest infection with PAC-MAN and AI
Researchers have developed techniques that can speed up the search for better tuberculosis drugs. They first measure which chemical compounds are able to slip across the outer membrane and then use those measurements to predict other compounds that can get into the Mtb cell.
-
NewsTuberculosis vaccine changes brain’s immune environment and Alzheimer’s biomarkers in older adults
A study shows that BCG vaccines can alter immune responses and amyloid-beta biomarkers in non-Alzheimer’s participants, which may help explain previously observed links to lower disease risk.